Latest Pfizer Inc News

CDC urges Pfizer booster for children ages 5 to 11

May. 19, 2022 19:23 PM EDT

Kids ages 5 to 11 should get a booster dose of Pfizer’s COVID-19 vaccine, advisers to the U.S. government said Thursday. The Center for Disease Control and Prevention quickly adopted the panel’s recommendation, opening a third COVID-19 shot to healthy elementary-age kids — just...

FDA clears COVID booster shot for healthy kids ages 5 to 11

May. 17, 2022 11:40 AM EDT

U.S. regulators on Tuesday authorized a COVID-19 booster shot for healthy 5- to 11-year-olds, hoping an extra vaccine dose will enhance their protection as infections once again creep upward. Everyone 12 and older already was supposed to get one booster dose for the best protection...

Asian stocks mixed, China gains ahead of US price data

May. 11, 2022 00:05 AM EDT

Shares were mixed in Asia on Wednesday with Chinese benchmarks pressing higher after a rally in technology companies helped reverse most of an early slide on Wall Street. Hong Kong's Hang Seng rose 1.1% to 19,853.66 and the Shanghai Composite index climbed 1.4% to 3,079.40. ...

Pfizer to spend $11.6B on migraine treatment maker Biohaven

May. 10, 2022 12:49 PM EDT

Pfizer is starting to put its COVID-19 cash influx to use by spending $11.6 billion to venture deeper into a new treatment area. The New York vaccine and cancer drug maker said Tuesday it will use cash on hand to buy the remaining portion of migraine treatment developer Biohaven...

WHO calls on Pfizer to make its COVID pill more available

May. 10, 2022 11:25 AM EDT

GENEVA (AP) — The head of the World Health Organization called on Pfizer to make its COVID-19 treatment more widely available in poorer countries, saying Tuesday that the pharmaceutical company's deal allowing generic producers to make the drug was insufficient. WHO...

Rare cases of COVID returning pose questions for Pfizer pill

May. 09, 2022 13:42 PM EDT

WASHINGTON (AP) — As more doctors prescribe Pfizer's powerful COVID-19 pill, new questions are emerging about its performance, including why a small number of patients appear to relapse after taking the drug. Paxlovid has become the go-to option against COVID-19 because of its...

FDA restricts J&J's COVID-19 vaccine due to blood clot risk

May. 06, 2022 00:29 AM EDT

WASHINGTON (AP) — U.S. regulators on Thursday strictly limited who can receive Johnson & Johnson’s COVID-19 vaccine due to the ongoing risk of rare but serious blood clots. The Food and Drug Administration said the shot should only be given to adults who cannot receive a...

BP, Clorox rise; Chegg, Expedia fall

May. 03, 2022 16:26 PM EDT

NEW YORK (AP) — Stocks that traded heavily or had substantial price changes Tuesday: Devon Energy Corp., up $5.93 to $64.28. The oil and gas exploration company reported strong first-quarter earnings and increased its stock buyback plan. Diamondback...

Pfizer profit soars in first quarter, revises 2022 forecast

May. 03, 2022 13:42 PM EDT

COVID-19 vaccine and treatment sales helped Pfizer breeze past Wall Street's first-quarter expectations, as the drugmaker's profit grew 61%. The coronavirus vaccine Comirnaty brought in more than $13 billion in sales in the quarter, and the company is still trying to expand the...

Pfizer hopes to submit little-kid vaccine data by early June

May. 03, 2022 13:23 PM EDT

Pfizer now hopes to tell U.S. regulators how well its COVID-19 vaccine works in the littlest kids by late May or early June. Pfizer is testing three extra-small doses of its vaccine in children under 5 after two shots didn't prove quite strong enough. Initial results had been...